🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Cancer Stage IV

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma NCT07189195Phase 11 site📍 Sacramento University of California, Davis · Tests: TR-002 Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer NCT05254171Phase 2, Phase 393 sites📍 Hot Springs📍 Fullerton📍 New Haven Panbela Therapeutics, Inc. · Tests: SBP-101, Nab-paclitaxel, Gemcitabine, Placebo BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion NCT07594626Phase 1, Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Pemetrexed, PRMT5 Inhibitor BMS-986504 Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer NCT06958328Phase 3333 sites📍 Gilbert📍 Gilbert📍 Peoria NRG Oncology · Tests: Biopsy Procedure, Biospecimen Collection, Capecitabine, Computed Tomography, Dose-escalated Radiation Therapy iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation NCT03608631Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients NCT06046794NA1 site📍 Marseille Institut Paoli-Calmettes · Tests: Analyze of GemCore status Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma NCT07226856Phase 23 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Gemcitabine, Imzokitug HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients NCT06770452Phase 22 sites📍 Hangzhou📍 Hangzhou Zhejiang University · Tests: HRS-4642, Nimotuzumab, gemcitabine + nab-paclitaxel OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma NCT07089940EARLY Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Myc Inhibitor OMO-103 Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma NCT07214298Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Fluorouracil, Irinotecan Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer NCT06017284Phase 31 site📍 Shanghai Fudan University · Tests: Thalidomide, Nab paclitaxel, Gemcitabine, Placebo Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors NCT05053971Phase 1, Phase 23 sites📍 New Haven📍 Gainesville📍 Oklahoma City National Cancer Institute (NCI) · Tests: BET Bromodomain Inhibitor ZEN-3694, Computed Tomography, Core Biopsy, Entinostat Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations NCT06998940Phase 3274 sites📍 Anchorage📍 Anchorage📍 Anchorage SWOG Cancer Research Network · Tests: Biospecimen Collection, Computed Tomography, Fluorouracil, Gemcitabine, Irinotecan Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma NCT05869474NA1 site📍 Shanghai Changhai Hospital · Tests: Iodine125-Seeds implantation, Gem/nab-P Chemotherapy KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer NCT06411691Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: KRAS Vaccine with Poly-ICLC adjuvant, Balstilimab, Botensilimab Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors NCT05687123Phase 110 sites📍 Duarte📍 Irvine📍 Orange National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging, Positron Emission To… A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations NCT06906562Phase 2109 sites📍 Birmingham📍 Mobile📍 Montgomery Sameek Roychowdhury · Tests: Pemigatinib, Computed Tomography (CT), Magnetic Resonance Imaging, Optical Coherence Tomography, Bone Scan Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer NCT06454383Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Cholestyramine, Computed Tomography, Diagnostic Imaging, Gemcitabine Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 NCT06084481Phase 154 sites📍 Duarte📍 San Francisco📍 Aurora AbbVie · Tests: ABBV-400, Itraconazole (ITZ), Bevacizumab Targeted Pathway Inhibition in Patients With Pancreatic Cancer NCT04005690EARLY Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Cobimetinib, Olaparib, Onvansertib, Azenosertib, Saruparib A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer NCT07701486Phase 1, Phase 21 site📍 Madrid Theriva Biologics SL · Tests: VCN-01 oncolytic adenovirus (zabilugene almadenorepvec), Nab-paclitaxel + Gemcitabine Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not NCT07273409NA4 sites📍 Gothenburg📍 Lund📍 Stockholm Uppsala University · Tests: Debulking surgery Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) NCT07733674Phase 11 site📍 Houston Radiomedix, Inc. · Tests: 203Pb-RMX-VHPIB injection, SPECT/CT Imaging Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders NCT00830557n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: medical chart review, survey administration, biospecimen collection Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites📍 Duarte📍 Los Angeles📍 Stanford Anusha Kalbasi · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate CREO - Microwave Ablation Feasibility Study NCT07817147NA7 sites📍 Gilbert📍 Los Angeles📍 Chicago Banner Health · Tests: EUS-Guided MWA Device Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: PICO G2 4k First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours NCT05759923Phase 13 sites📍 Bydgoszcz📍 Otwock📍 Warsaw Molecure S.A. · Tests: OATD-02
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy